One of the participants in the COVID-19 vaccine trial died: the study was not suspended - ForumDaily
The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

One of the participants in the COVID-19 vaccine trial died: the study was not suspended

On Wednesday, October 21, Brazilian health authority Anvisa announced that a volunteer involved in a trial of a COVID-19 vaccine being developed by AstraZeneca and the University of Oxford has died. An investigation into the exact cause of death is underway; vaccine trials have not yet been suspended. Details told the publication Fox News.

Photo: Shutterstock

Local media reported that the deceased was a man from Rio de Janeiro, he was about 20 years old. It is not yet known whether the man was vaccinated or was part of the placebo group.

An anonymous source said that if the victim had been vaccinated, the research would have been suspended.

A spokesman for AstraZeneca said the company was unable to comment on individual cases in the ongoing COVID-19 vaccine trial due to regulations. However, he stressed that the company has completed all the necessary verification procedures.

“All significant medical events are carefully assessed by trial investigators, an independent safety monitoring committee and regulatory authorities,” the spokesperson said. “These assessments did not raise any concerns regarding the continuation of the current study.”

On the subject: A vaccine that partially protects against COVID-19 already exists

In the U.S. clinical trials of AstraZeneca are suspended pending investigation by the US Food and Drug Administration (FDA) due to a "possible serious adverse event" in one of the volunteers. The head of the Department of Health and Human Services, Alex Azar, told reporters that he was not aware of any plans to reopen the trials as the case is still pending with the FDA.

In June, Brazil announced a deal to buy 100 million doses of a potential COVID-19 vaccine if it is found to be safe and effective. At the time, Brazilian President Jair Bolsonaro, who had recovered from COVID-19 himself, said the money was meant to be invested in research and purchase of a "batch of vaccines."

The country ranks second in the world in the number of coronavirus-related deaths and third in the number of infected people (more than 5,3 million cases).

Read also on ForumDaily:

Covidiot and coronicles: 7 new words that emerged during the pandemic

Three months or longer: who and why is the protracted course of COVID-19 threatened

Scientists have discovered a new feature of COVID-19 that changes the perception of the disease

Card, money and smartphone: coronavirus can live on some surfaces for up to 4 weeks

A vaccine that partially protects against COVID-19 already exists

CDC recognizes another way coronavirus spreads

WHO: there may be 20 times more people infected with coronavirus than officially recognized

Miscellanea vaccine Incidents coronavirus Special Projects
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis. 



 
1068 requests in 1,280 seconds.